Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178033 | SCV000230018 | uncertain significance | not provided | 2017-06-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001242627 | SCV001415726 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2022-06-13 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 195 of the CAPN3 protein (p.Asn195Ser). This variant is present in population databases (rs148855999, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 197101). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000178033 | SCV003828933 | uncertain significance | not provided | 2022-05-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178033 | SCV004031030 | uncertain significance | not provided | 2023-07-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001242627 | SCV002094450 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2019-10-28 | no assertion criteria provided | clinical testing |